Simplex Trading, LLC Caladrius Biosciences, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.41 - $0.74 $7,742 - $13,974	-18,885 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$0.63 - $1.03 $11,897 - $19,451	18,885 New	18,885 $13,000
Q1 2021 Apr 26, 2021	SELL	$1.44 - $2.89 $22,062 - $44,277	-15,321 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$1.39 - $1.87 $9,446 - $12,708	6,796 Added 79.72%	15,321 $21,000
Q3 2020 Oct 14, 2020	BUY	$1.6 - $3.0 $13,640 - $25,575	8,525 New	8,525 $15,000
Q2 2020 Jul 13, 2020	SELL	$1.66 - $2.38 $1,503 - $2,156	-906 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$1.21 - $3.47 $1,003 - $2,876	829 Added 1076.62%	906 $1,000
Q4 2019 Feb 05, 2020	BUY	$2.02 - $2.85 $155 - $219	77 New	77 $0
Q3 2019 Oct 15, 2019	SELL	$2.22 - $2.99 $26 - $35	-12 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$2.25 - $3.6 $27 - $43	12 New	12 $0

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.